Prevent, Detect, Respond: Mastering Risk and Integrity in Clinical Trials

What if risk management in clinical trials was not about reacting faster — but about thinking differently from the start?

In an environment where complexity, data volume, and operational pressure continue to grow, traditional monitoring approaches are no longer sufficient. The future belongs to teams that can anticipate risk, detect weak signals early, and act decisively before issues escalate.

This session will challenge the conventional view of the CRA role and clinical oversight, exploring how centralized monitoring, critical thinking, and a culture of ownership can transform how we safeguard trial integrity.

It will also address how to respond effectively when risks materialize, including the management of serious breaches, misconduct, and potential fraud, while safeguarding trial integrity.

Participants will leave with a clearer understanding of how to elevate their role in risk oversight and contribute to more resilient, high-quality clinical trial delivery.